课题基金 / 基金详情

Mutational signature analysis: methods and applications to the clinic

Mutational signature analysis: methods and applications to the clinic
突变特征分析:方法和临床应用
批准号:
10418967
负责人:
Peter J Park
金额:
$45.32万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-05-05 至 2027-04-30

项目摘要

项目成果

Peter J Park的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY Mutational signature analysis is a recent analytical approach for interpreting somatic mutations in the genome. It utilizes the sequence context of point mutations as well as the size and type of copy number and structural aberrations to decompose the observed mutational patterns into distinct 'signatures', some of which have been associated with specific biological processes. In this project, we will develop more robust and sensitive com- putational methods for mutational signature analysis and apply them to several clinically important questions. Our initial work has attracted a great deal of attention from clinicians, and we will analyze data from several clinical cohorts in close collaboration. In Aim 1, we will build upon our previous work to devise a method that can identify homologous recombination deficiency in cancer patients profiled on gene panels. Although whole-genome sequencing offers several advantages, gene panel sequencing remains as a pivotal platform in clinical care. Our method will enable signature analysis for gene panels from which only a small number of mutations can be observed. We will incorporate additional sources of information and identify biomarkers for patient stratification. In Aim 2, we will investigate other types of genomic instability such as mismatch repair deficiency, replication stress, and APOBEC mutagenesis. For example, although patients with mismatch repair deficiency generally respond better to immunotherapy, there is a considerable variation across patients. We will use mutational signatures to identify a subset of patients that respond better. In Aim 3, we will extend our method to data from circulating tumor DNA and single cell RNA sequencing to enable signature-based predictive modelling. In Aim 4, we will develop a generalized analytical framework for whole-genome and whole-exome signature analysis that will overcome the shortcomings of current approaches. We will use this new framework to build a high-quality reference catalog for the community.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Data Analysis Center for Somatic Mosaicism Across Human Tissues Network
  • 批准号:
    10662721
  • 项目类别:
  • 资助金额:
    $200.0万
  • 财政年份:
    2023
  • 负责人:
    Peter J Park
  • 依托单位:
Development of an Efficient High Throughput Technique for the Identification of High-Impact Non-Coding Somatic Variants Across Multiple Tissue Types
  • 批准号:
    10662860
  • 项目类别:
  • 资助金额:
    $44.83万
  • 财政年份:
    2023
  • 负责人:
    Peter J Park
  • 依托单位:
Mutational signature analysis: methods and applications to the clinic
  • 批准号:
    10618248
  • 项目类别:
  • 资助金额:
    $44.43万
  • 财政年份:
    2022
  • 负责人:
    Peter J Park
  • 依托单位:
Interoperability and Collaboration with the Common Fund Data Ecosystem to Improve Utility of 4DN Data
  • 批准号:
    10683513
  • 项目类别:
  • 资助金额:
    $54.03万
  • 财政年份:
    2021
  • 负责人:
    Peter J Park
  • 依托单位:
海外基金